Sie sind auf Seite 1von 4

 CYSTIC FIBROSIS Sandra H.

Reid MSN, RN-C

 Objectives

 Discuss pathophysiology & clinical manifestations of CF

 Formulate collaborative strategies to promote optimal functioning of the child with CF

 Identify learning needs of the family R/T medication administration, therapies & nutritional requirements

Autosomal Recessive Disorder

Heredity

 Racial Differences

 ( But …Not apply to individuals)

 From all walks of life

 Most common fatal heredity disease

 30,000 Americans, 1: 3,300 live births

 Disease of the exocrine glands

 Body not brain

Features

 Viscosity of mucous

 Sweat electrolytes

 Change in saliva

 Abnormalities in autonomic nervous system function

 Abnormal chloride movement, Pancreatic insufficiency

Effects of Increased Viscosity

 Mechanical Obstruction

 Meconium Ileus & Rectal Prolapse

 Liver

 Biliary obstruction

• Malnutrition & Cirrhosis

• Portal hypertension , Esophageal varices & blebs


 Pancreas

 Fibrotic Enzymes Malabsorption

 Pulmonary System

 Life threatening / Variable age of onset

 Patchy atelectasis, Hyperinflation, Emphysema

 O2 – CO2 Exchange

 Hypoxia, Hypercapnia, Acidosis

 Increased Infection

 Reproductive System

 Female

• Cervical Mucous Plug

 Male

• Abnormal Wolffian Ducts, > 95% Sterility

Diagnosis

 Familial history

 Sweat chloride test

 Taste “salty”

 Cl > 60 mEq/L, (norm < 40 mEq/L)

 Na & Cl 3 to 5 x higher

 Lack Pancreatic Enzymes

 Stool Analysis

 Pulmonary Involvement

 Chest X ray, PFT’s

Clinical Findings

 Infancy

 _______________, _______________, _______________, _______________


 Cardiac Enlargement

 Rt ventricular hypertrophy

 Evidence of Chronic Respiratory involvement

 B_________ shaped chest, Clubbing, Cyanosis / Pallor & Distended neck veins, Fatigue

Therapeutic Management

 Prevent & Tx. Respiratory Infections

 Improve aeration

• B_______________

• Recombinant human deoxyribonuclease

• E_______________

 Remove secretions

• CPT – minimum 2x / day

• Flutter mucus clearance device, Vibration

• No Antihistamines

 Anti-microbial agents

• Sputum C&S

• Central venous access

• Vaccinate for pneumococcus & influenza

 Oxygen (humidified), Pneumothorax – (s/s?)

 Promote Optimal Nutrition

 High Protein / High Calorie

• 150%, Normal Fat, ? Salt

 Replace pancreatic enzymes

• 1-5 Capsules, Sprinkle

 Infancy

 Vitamins, Tube Feedings, PN

 Skin care
 Provide Emotional Support & Counseling

 _________________________

 _________________________

 _________________________

 _________________________

 _________________________

 _________________________

Prognosis

 Pulmonary involvement

 40 years of advancement & research

 Improved length & quality of life

 Carrier screening

 Gene Therapy / Lung transplants

 Remains progressive & incurable

Das könnte Ihnen auch gefallen